{
    "Trade/Device Name(s)": [
        "ELITech Clinical Systems BILIRUBIN TOTAL 4+1",
        "ELITech Clinical Systems BILIRUBIN DIRECT 4+1"
    ],
    "Submitter Information": "ELITech Clinical Systems SAS",
    "510(k) Number": "K171401",
    "Predicate Device Reference 510(k) Number(s)": [
        "K060325"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CIG"
    ],
    "Summary Letter Date": "May 3, 2017",
    "Summary Letter Received Date": "May 12, 2017",
    "Submission Date": "July 11, 2017",
    "Regulation Number(s)": [
        "21 CFR 862.1110"
    ],
    "Regulation Name(s)": [
        "Bilirubin (total or direct) test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Total bilirubin",
        "Direct bilirubin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ELITech Clinical Systems Selectra Pro Series Analyzers",
        "Selectra ProM Analyzer",
        "Selectra Series Analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Diazo colorimetry",
        "End point analysis"
    ],
    "Methodologies": [
        "Malloy-Evelyn modified colorimetric assay"
    ],
    "Submission Type(s)": [
        "Kit",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for ELITech Clinical Systems BILIRUBIN TOTAL 4+1 and BILIRUBIN DIRECT 4+1 reagents for quantitative determination of total and direct bilirubin on Selectra Pro Series analyzers.",
    "Indications for Use Summary": "For quantitative in vitro diagnostic determination of total and direct bilirubin in human serum and plasma on ELITech Clinical Systems Selectra Pro Series Analyzers; not intended for use in point of care settings.",
    "fda_folder": "Clinical Chemistry"
}